Causal genes and variants within genome-wide association study (GWAS) loci 43 can be identified by integrating GWAS statistics with expression quantitative trait 44 loci (eQTL) and determining which SNPs underlie both GWAS and eQTL signals. 45
show that analyzing conditional eQTL signatures, which could be important under 48 specific cellular or temporal contexts, leads to improved fine mapping of GWAS 49 associations. Using genotypes and gene expression levels from post-mortem 50 human brain samples (N=467) reported by the CommonMind Consortium (CMC), 51 we find that conditional eQTL are widespread; 63% of genes with primary eQTL 52 also have conditional eQTL. In addition, genomic features associated with 53 conditional eQTL are consistent with context specific (i.e. tissue, cell type, or 54 developmental time point specific) regulation of gene expression. Integrating the 55
Psychiatric Genomics Consortium schizophrenia (SCZ) GWAS and CMC 56
conditional eQTL data reveals forty loci with strong evidence for co-localization 57 (posterior probability >0.8), including six loci with co-localization of conditional 58 eQTL. Our co-localization analyses support previously reported genes and 59 identify novel genes for schizophrenia risk, and provide specific hypotheses for 60 their functional follow-up. serve as a link between the numerous non-coding genetic associations that have 72 been identified in GWAS and susceptibility to common diseases directly through 73 their association with gene expression regulation. [1] [2] [3] [4] Indeed, results from eQTL 74 mapping studies have been successfully utilized to identify genes and causal 75 variants from GWAS for various complex phenotypes, including asthma, body 76 mass index, celiac disease, and Crohn's disease.
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Studies integrating eQTL and GWAS data have almost exclusively used marginal 79 association statistics which typically represent the primary, or most significant, 80 eQTL signal when assessing co-localization with GWAS, ignoring other SNPs 81 that affect expression independently of the primary eQTL for a given gene. 82
However, recent findings indicating that conditionally independent eQTL are 83 widespread 9-11 motivate examination of the extent to which considering 84 conditional eQTL may provide additional power to identify likely causal genes in a 85 GWAS locus. Recent reports provide evidence that conditional eQTL are less 86 to calculate developmental period specificity (Tau). Each Tau was added to the 223 above modeling of eQTL number in turn, as well as all together. 224 225
Enrichment Analyses 226 227
We divided eQTL into separate subgroups by stepwise conditional order (first, 228 second, third, and greater than third), and created sets of matched SNPs drawn 229 from the SNPsnap database for each subgroup, matching on minor allele 230 frequency, gene density (number of genes within 1Mb of the SNP), distance from 231 SNP to TSS of the nearest gene, and LD (number of LD-partners within r 2
0.8). 232
For each subgroup of eQTL, we performed a logistic regression of status as 233 eQTL or matched SNP on overlap with functional annotation, including the four 234 SNP matching parameters as covariates. Enrichment was taken as the 235 regression coefficient estimate, interpretable as the log-odds ratio for being an 236 eQTL given a functional annotation. 
Conditional eQTL Analyses 248 249
In order to isolate each conditionally independent cis-eQTL association, we 250 carried out a series of "all-but-one" conditional analyses, implemented within 251
MatrixEQTL
15 , for each gene possessing more than one independent eQTL. As 252 these conditional eQTL signals were to be used to test for co-localization with the 253 SCZ GWAS signals, we limited these analyses to those genes (346 in total) with 254 eQTL overlapping GWAS loci. For each of these genes, we conducted an '"all-255 but-one" analysis for each independent eQTL by regressing the given gene's 256 expression data on the dosage data, including all of the other independent eQTL 257 for that gene as covariates in addition to diagnosis and five ancestry 258 components. For example, three conditional analyses would be conducted for a 259 gene with three independent eQTL: one analysis conditioning on the secondary 260 and tertiary eQTL, one analysis conditioning on the primary and tertiary, and one 261 analysis conditioning on the primary and secondary. In this manner we generated 262 summary statistics for each independent eQTL in isolation, conditional on all of 263 the other independent eQTL for that gene. 
Co-localization Analyses 268 269
For our co-localization analyses, we used summary statistics and genomic 270 intervals from the 2014 PGC SCZ GWAS. 27 We included 217 loci at a P-value 271 threshold of 1x10 -6 (omitting the complex MHC locus), defined these loci by their 272 LD r 2 0.6 with the lead SNP, and then merged overlapping loci. GWAS and 273 eQTL signatures were qualitatively compared using P-P plots, rendered in R, and 274
LocusZoom 28 plots. 275
276
We tested for co-localization using an updated version of COLOC 29 R functions, 277 which we name COLOC2 (see Web Resources) which incorporates several 278 improvements to the method. First, COLOC2 preprocesses data by aligning 279 eQTL and GWAS summary statistics for each eQTL cis-region. Second, the 280 COLOC2 model optionally incorporates changes implemented in gwas-pw 30 . 281
Briefly, we implemented learning mixture proportions of five hypotheses (H0, no 282 association; H1, GWAS association only; H2, eQTL association only; H3, both but 283 not co-localized; and H4, both and co-localized) from the data. COLOC2 uses 284 these proportions as priors (or optionally, COLOC default or user specified priors) 285 in the empirical Bayesian calculation of the posterior probability of co-localization 286 for each locus (eQTL cis-region European-ancestry cases and controls).
14 We identified 16,273 conditional eQTL 299 in addition to the 13,137 primary eQTL we previously reported 14 for a total of 300 29,410 independent cis-eQTL for 15,817 autosomal genes. Of the genes tested, 301 81% (12,813 genes) had at least one eQTL and 63% of these (51% of all genes) 302 also had at least one conditional eQTL, with an average of 1.83 independent 303 eQTL per gene (2.26 among those with at least one eQTL), and a maximum of 304 16 eQTL (Figure 1) . Conversely, when examining the distributions for the number 305 of genes whose expression was affected by each eQTL (Table S1), the majority 306 of eQTL were specific for a single gene, and only a small fraction of eQTL, 307
1.47%, affected more than one gene, with a maximum of six genes affected by a 308 single eQTL. 309
310
We tested conditional eQTL for replication in two independent data sets, the analysis in the CMC data. We observed strong evidence of replication for both 316 primary and conditional eQTL in the HBCC and ROSMAP post-mortem brain 317 cohorts ( Table S2 ). The estimated proportion of true associations (π1) in 318 ROSMAP was 0.57 and 0.26 for primary and conditional eQTL, respectively; in 319 HBCC π1 was 0.46 and 0.20 for primary and conditional eQTL. Thus replication 320 was stronger for primary than for conditional eQTL, as expected given their 321 stronger effect sizes. Replication rates were somewhat higher in the RNA-seq 322 ROSMAP data than in HBCC. 323
324
Genomic Characterization of Primary and Conditional eQTL 325 326
According to prior results, eQTL that are shared across tissues and cell types 327 tend to be located closer to transcription start sites (TSS) than context specific 328 eQTL.
9; 12; 13 We therefore examined the relationship between primary or 329 conditional eQTL status and distance to its gene's transcription start site. Both primary and conditional eQTL were significantly enriched in both promoter 390 and enhancer chromatin states ( Figure 3A -B, Table S4 ). Chromatin states from 391 the DLPFC showed stronger eQTL enrichment than did the Brain annotation 392 formed by merging all individual brain region chromatin states. We found that 393 enrichments in both the DLPFC and Brain annotations generally decreased with 394 higher conditional order of eQTL, particularly for the active promoter state. A 395 similar pattern was observed when examining enrichment in neuronal nuclei 396 (NeuN+) ChIP-seq peaks ( Figure 3C ), using the overlap of H3K4me3 and 397
H3K27ac ChIP-seq peaks as a proxy for active promoters and H3K27ac peaks 398 that do not overlap H3K4me3 peaks as a (relatively non-specific) proxy for 399 enhancers. 26 These analyses showed decreasing enrichment in both promoters 400 and enhancers with increasing eQTL order, with a more marked decrease in the 401 promoters. Though there was also significant enrichment of eQTL in non-402 neuronal nuclei (NeuN-) ChIP-seq peaks, decreasing with higher eQTL order, 403 this trend of a more marked decrease in active promoters was not observed in H2, eQTL association only; H3, both but not co-localized; and H4, both and co-426 localized). We then used these probabilities as priors to calculate empiricalBayesian posterior probabilities for the five hypotheses for each locus, in 428 particular PPH4 for co-localization. 429
430
For genes with conditional eQTL overlapping SCZ GWAS loci, summary 431 statistics from "all-but-one" conditional eQTL analyses were assessed for co-432 localization with the GWAS signature (Figure 4 
but-one" conditional analyses, in each analysis conditioning on all but a focal 438 independent eQTL (for IREB2 this entailed conditioning on only one eQTL per 439 conditional analysis, but involved conditioning on up to six eQTL across genes in 440 the SCZ co-localization analysis). We then tested for co-localization between the 441 GWAS and all of the conditional summary statistics using COLOC2. In the case 442 of IREB2, the conditional eQTL (rs7171869) was implicated as co-localized with 443 the GWAS signal at this locus with a posterior probability for co-localization PPH4 444 = 0.94. A qualitative examination of the IREB2 locus supported the COLOC2 445 results: the correlation between the GWAS P-values and conditional eQTL P-446 values was higher than that between the GWAS and primary eQTL P-values 447 ( Figure 5A ). In addition, the GWAS signature for the locus more closely 448 resembled the conditional eQTL signature than either the non-conditional eQTL 449 signature or the primary eQTL signature ( Figure 5B ). We found that 40 loci contained genes with strong evidence of co-localization 452 between eQTL and GWAS signatures, with posterior probability of H4 (PPH4) 453 0.8 (Table 2, Table S6 ). When restricting to genome-wide significance for the 454 GWAS, we found co-localization in 24 of the 108 loci. Given the correlations 455 between number of independent eQTL and expression specificity scores (Tau) 456 across tissues, cell types and development, we tabulated the reported genes' 457 Tau percentiles and expression levels, to highlight contexts in which the genes 458 are specifically expressed ( Table 2, Table S9 ). We acknowledge that while 459 posterior probability PPH4 0.8 demonstrates strong Bayesian evidence for co-460 localization, it is an arbitrary threshold for characterizing loci as SCZ-eQTL co-461 localized; we find that many loci with PPH4 0.5 appear qualitatively consistent 462 with co-localization. 463 464 Importantly, for six of the 40 co-localizing loci, a conditional rather than primary 465 eQTL co-localized with the GWAS with compelling qualitative support ( Table 2 , 466 
Comparison with Previous Co-localization Analyses 474 475
In our prior analyses 14 we reported a co-localization analysis of the 108 genome-476 wide significant schizophrenia GWAS loci and non-conditional eQTL using 477
Sherlock. 40 Those results and our current findings are highly concordant ( Table  478 S7). Eleven loci were reported as co-localized in both analyses. Thirteen loci 479 were co-localized (PPH4 0.8) in our analysis but not previously, twelve of which 480 showed suggestive significance in Sherlock (P<2x10 -4 ), or in one case involved a 481 conditional eQTL (SLC35E2) in our analysis. Six loci were co-localized in the 482 previous study but not in the current analysis; three of these resulted from 483 differences in study design such as GWAS locus definition and eQTL overlap 484 criteria, and two were suggestive in the current analysis (0.65< PPH4 <0.8). The 485 one remaining discrepant locus (chr8:143302933-143403527) was found to co-486 localize with TSNARE1 eQTL previously (Sherlock P=8.24x10 -7 ), but not here 487 (COLOC2 primary eQTL PPH4=0.074, PPH3=0.93), and indeed a qualitative 488 comparison of the eQTL and GWAS data did not appear to support co-489 localization ( Figure S13) . 490
491
In the present analysis we considered not only primary but also conditional eQTL 492 association signals for co-localization with the GWAS, allowing us to detect loci 493 where co-localization may be obscured by multiple association signals in non-494 conditional eQTL analysis. We also compared our conditional co-localization 495 results with results using non-conditional eQTL analysis, using the sameCOLOC2 method and SCZ GWAS loci (Table S8) . Conditional and non-497 conditional COLOC2 results were highly concordant, with slightly higher PPH4s 498 resulting from the same WABFs because of a higher prior probability of co-499 localization estimated in the non-conditional COLOC2 analysis. Thirty-five loci 500 were co-localized in both analyses, and five loci that were co-localized in the 501 non-conditional analysis only were all highly suggestive in the conditional 502 analysis (0.65 < PPH4 < 0.8). The five loci that were co-localized only in the 503 conditional COLOC2 analysis involved conditional and not primary eQTL. 504 505 DISCUSSION 506
507
We utilized genotype and expression data from 467 human post-mortem brain 508 samples from the DLPFC to conduct eQTL mapping analyses, to characterize 509 both primary and conditionally independent eQTL. We then identified co-510 localization between SCZ GWAS and our eQTL association signals, including 511 conditional eQTL. Our principal findings include four major observations. First, 512
we detect that conditional eQTL are widespread in the brain tissue samples we 513 investigated. In 63% of genes with at least one eQTL, we found multiple 514 statistically independent eQTL (8,136 genes). This demonstrates that genetic 515 variation affecting RNA abundance is incompletely characterized by focusing 516 only on one primary eQTL per gene, which is the case currently for most eQTL 517 studies. We suggest that these conditional eQTL may represent regulatory 518 variation specific to biological contexts not necessarily well represented in the 519 transcriptomic data at hand. 520 521 Second, we find the genomics of conditional eQTL and their genes are consistent 522 with complex, context-specific regulation of gene expression. Conditional eQTL 523 occur farther from transcription start sites than primary eQTL, consistent with 524 effects on distal regulatory elements. Genes with more independent eQTL tend 525 to be larger and span multiple recombination hotspot intervals, and tend to be 526 less constrained at the protein level. While these associations may reflect in part 527 greater power to detect independent eQTL that are not in linkage disequilibrium 528
and that have greater phenotypic variance, they are also consistent with more 529 complex regulation and greater potential for regulatory genetic variation. The 530 strong association of eQTL number with gene expression cis-SNP-heritability 531
shows that conditional eQTL contribute to regulatory genetic variation. 532
Importantly, associations with specificity of expression across tissues, 533 developmental periods, and cell types determined from single-cell RNA 534 sequencing data, suggest that context specificity plays a role in the occurrence of 535 multiple statistically independent eQTL. Cell type specificity is particularly 536 strongly correlated with eQTL number, consistent with those cell types being 537 present in the current tissue-homogenate data. 538
539
Both primary and conditional eQTL are enriched in both active promoter and 540 enhancer regions, and their enrichment in active promoters diminishes with 541 increasing conditional eQTL order. In other words, conditional eQTL show 542 greater enrichment in enhancers relative to promoters than do primary eQTL. We 543 note that these enrichment analyses are less well powered for conditional eQTL 544 than for primary eQTL, both because of smaller effect sizes of conditional eQTL, 545 and because of statistical error introduced by forward stepwise conditional 546 analyses.
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Third, we highlight the importance of examining conditional eQTL for co-549 localization with GWAS. In at least six out of 40 loci showing GWAS-eQTL co-550 localization, a conditional eQTL signal co-localizes with SCZ risk. If we had 551 considered only primary eQTL in the analyses, these instances of co-localization 552 would have been missed. Conditional eQTL that co-localize with disease risk 553 may reflect regulatory mechanisms that are important in a key developmental 554 period or individual cell type, and may be missed when focusing on primary 555 eQTL discovered in adult whole tissue. As further efforts are made to generate 556 data across ranges of tissues or individual cell-types, we may have a better 557 ability to directly identify regulatory variants specific to these contexts. However if 558 a variant is primarily active in a very specific time point or stimulus condition, 559 capturing data reflecting this condition will remain challenging. Conditional co-560 localization analysis in well-powered eQTL cohorts may best identify the genes 561 driving these trait associations, though further validation work will be required to 562 understand the mechanism by which the gene contributes to disease risk. 563 Fourth, we have identified a number of candidate genes for which genetic 565 variation for expression co-localizes with genetic variation for schizophrenia risk 566 ( In an effort to highlight specific developmental periods or cell types for follow-up, 583
we have tabulated expression specificity in GTEx tissues, brain sample cell types 584 from single-cell RNA-seq, 23 and in BrainSpan DLPFC developmental periods, for 585 all identified genes ( Table 2, Table S9 ). Their expression contexts show a 586 diversity of patterns, and can provide clues to generate specific hypotheses for 587 functional follow-up of their potential roles in SCZ. Among DLPFC cell types, we 588 find several genes that are specific to neurons and examples of genes specific to 589 oligodendrocytes or endothelial cells (Table 2) . Among DLPFC developmental 590 periods, we see diverse expression patterns ranging from early prenatal and 591 broader prenatal, to perinatal (late prenatal and infancy periods), to 592 adolescent/adult expression. We note no clear pattern of correlation between cell 593 type and developmental expression patterns, for example neuronal cell type 594 expressed genes include genes with prenatal, perinatal and postnatal 595 expression. Interestingly, however, all genes broadly expressed across cell types 596 show prenatal expression (Table S9) . 597 598 IREB2 (iron regulatory element binding protein 2), highlighted in our analyses as 599 a conditional eQTL hit, is a key regulator of iron homeostasis 48; 49 and has been 600 implicated in neurodegenerative disorders.
50; 51 Mouse IREB2 homolog Irp2 601 knockouts exhibit impairments in coordination and balance, exploration, and 602 nociception. 49 The IREB2 locus includes the CHRNA3-CHRNA5-CHRNB4 603 nicotinic receptor cluster associated with schizophrenia 27 as well as nicotine 604 dependence and smoking behavior, 52 lung cancer, 53; 54 and COPD. 55 We note 605 that the IREB2 conditional eQTL is associated with CHRNA3 and CHRNA5 606 expression in cerebellum, caudate and some non-brain tissues in GTEx, but both 607 genes are too lowly expressed for eQTL analysis in the CMC DLPFC samples. 64 Consistent with a role in immune-mediated synaptic pruning, STAT6 620 expression is broadly postnatal and specific to microglia and neurons (Table S9) . 621
622
Finally, a conditional eQTL for PROX1 Antisense RNA 1 (PROX1-AS1; chr1, 623 214Mb) co-localizes with a suggestive SCZ locus (P=9.7x10 -7 ). The Prospero 624 Homeobox 1 (PROX1) transcription factor, involved in development and cell 625 differentiation in several tissues, including oligodendrocytes 65 and GABAnergic 626 interneurons 66 in the brain. This lncRNA has been implicated as aberrantly 627 expressed in several cancers, is upregulated in the cell cycle S-phase, and 628 promotes G1/S transition in cell culture. 67 Like STAT6, PROX1-AS1 expression is 629 specific to neurons and mature oligodendrocytes, and is expressed postnatally 630 (Table S9) . 631
